There was some moderate-to-serious hand-wringing the other day when it was revealed that Bartolo Colon received an injection of his own stem cells to help repair ligaments. As David Epstein notes in a very informative article over at SI, however, the hand-wringing is unwarranted. Colon’s procedure is fairly commonplace and, in its general effect, is no different than microfracture surgery, which no one thinks is a problem.
He likens the response to Colon’s procedure to another procedure — platelet rich plasma therapy — that caused people to freak out a little bit in recent years. In both cases, however, the therapy itself is noncontroversial. The source of the controversy was the doctor at the center of the particular case: Anthony Galea in PRP and Joseph R. Purita in the case of Colon’s stem cell thing. Galea remains in legal trouble over his alleged use, purchase and transport of HGH. Purita because he admitted that in his non-athlete patients he uses HGH in the stem cell therapy.
Given the level of misinformation and ignorance floating around sports media and among fans when it comes to things like PEDs, it’s not surprising that new-to-us medical procedures lead to raised eyebrows. But we should all understand that, for the vast majority of us, when we talk about medicine, we really don’t know what the hell we’re talking about.
On Sunday, it was reported that second baseman Neil Walker and the Mets were discussing a potential three-year contract extension worth “north of $40 million.” Those discussions took a turn for the worse. The Mets feel extension talks are “probably dead,” according to Mike Puma of the New York Post.
Walker underwent a lumbar microdisectomy in September, ending his 2016 season during which he hit .282/.347/.476 with 23 home runs and 55 RBI over 458 plate appearances.
The Mets may not necessarily need to keep Walker around as it has some potential options up the middle waiting in the minor leagues. Though Amed Rosario is expected to stick at shortstop, Gavin Cecchini — the club’s No. 3 prospect according to MLB Pipeline — could shift over to second base.
The story of Rick Ankiel is well known by now. He was a phenom pitcher who burst onto the scene with the Cardinals in 1999 and into the 2000 season as one of the top young talents in the game. Then, in the 2000 playoffs, he melted down. He got the yips. Whatever you want to call it, he lost the ability to throw strikes and his pitching career was soon over. He came back, however, against all odds, and remade his career as a solid outfielder.
It’s inspirational and incredible. But there is a lot more to the story that we’ve ever known. We will soon, however, as Ankiel is coming out with a book. Today he took to the airwaves and shared some about it. Including some amazing stuff:
On drinking in his first start after the famous meltdown in Game One of the 2000 National League division series against the Braves:
“Before that game…I’m scared to death. I know I have no chance. Feeling the pressure of all that, right before the game I get a bottle of vodka. I just started drinking vodka. Low and behold, it kind of tamed the monster, and I was able to do what I wanted. I’m sitting on the bench feeling crazy I have to drink vodka to pitch through this. It worked for that game. (I had never drank before a game before). It was one of those things like the yipps, the monster, the disease…it didn’t fight fair so I felt like I wasn’t going to fight fair either.”
Imagine spending your whole life getting to the pinnacle of your career. Then imagine it immediately disintegrating. And then imagine having to go out and do it again in front of millions. It’s almost impossible for anyone to contemplate and, as such, it’s hard to judge almost anything Ankiel did in response to that when he was 21 years-old. That Ankiel got through that and made a career for himself is absolutely amazing. It’s a testament to his drive and determination.